science

The new Musk master plan? Wedbush sees SpaceX and Tesla merging

Syndax Pharmaceuticals’ SWOT analysis: stock gains momentum on strong launch

"As a bonus, it captured Mars images from a rare perspective."

cbdMD extends Charlotte lease with reduced space and rent through 2031

Elon Muks's xAI said it will buy $2.8 billion worth of natural gas turbines over the next three years, according to SpaceX's IPO filing.

Teva Pharmaceutical’s SWOT analysis: stock navigates growth reset

SpaceX’s $20.7 Billion in 2025 CapEx Fueled by AI, Spacecraft

Lilly bets up to $202M in non-viral genetic medicines in Engage Bio buyout

SAN CARLOS, Calif.--(BUSINESS WIRE)--Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is developing the Tethosome platform, a novel non-viral DNA delivery syst

Lilly bets up to $202M in non-viral genetic medicines in Engage Bio buyout